FDA
approval
· 2023-06-02
FDA Approved: EPLERENONE — Original Application (Camber Pharmaceuticals, Inc.)
Summary
FDA approves Camber Pharmaceuticals' Original Application for a generic version of eplerenone (Inspra).
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
ORIG AP for EPLERENONE (EPLERENONE)